Drugs / AMA1-DiCo
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02014727 | Jan 2014 → Mar 2015 | Plasmodium falciparum malaria | French National Institute of Health and Medical Research | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMA1-DiCo | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02014727 ↗ |
| Known as | PfAMA1-DiCo | “Plasmodium falciparum Apical Membrane Antigen 1 Diversity Covering (PfAMA1-DiCo) candidate vaccine is a formulation of three recombinant variants of AMA1 designed to provide...” PMID 28947345 ↗ Sep 2017 |
| Modality | Vaccine | “PfAMA1-DiCo) candidate vaccine” PMID 28947345 ↗ Sep 2017 |
| Route | Intramuscular | “AMA1-DiCo (50µg) was administered intramuscularly at baseline, Week 4 and 26.” PMID 28947345 ↗ Sep 2017 |